Qiaoling Xie
Chongqing, 400038, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
An exploratory machine learning model for predicting advanced liver fibrosis in autoimmune hepatitis patients: A preliminary study.
Journal: Annals of hepatology
Published: May 18, 2024
Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylation.
Journal: Hepatology (Baltimore, Md.)
Published: January 12, 2024
Dimethyl fumarate attenuates cholestatic liver injury by activating the NRF2 and FXR pathways and suppressing NLRP3/GSDMD signaling in mice.
Journal: Experimental cell research
Published: January 18, 2023
Semaphorin 7A interacts with nuclear factor NF-kappa-B p105 via integrin β1 and mediates inflammation.
Journal: Cell communication and signaling : CCS
Published: October 19, 2022
Runt-related transcription factor-1 ameliorates bile acid-induced hepatic inflammation in cholestasis through JAK/STAT3 signaling.
Journal: Hepatology (Baltimore, Md.)
Published: July 27, 2022
Melatonin attenuates cholestatic liver injury via inhibition of the inflammatory response.
Journal: Molecular and cellular biochemistry
Published: April 09, 2022
Tumor necrosis factor α upregulates the bile acid efflux transporter OATP3A1 via multiple signaling pathways in cholestasis.
Journal: The Journal of biological chemistry
Published: December 09, 2021
A novel role for interleukin 32 in cholestasis.
Journal: Clinical and translational medicine
Published: June 28, 2021
Unique DUOX2+ACE2+ small cholangiocytes are pathogenic targets for primary biliary cholangitis.
Journal: Nature communications
Published: June 04, 2021
A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasis.
Journal: EMBO molecular medicine
Published: May 17, 2021
Last Updated: 09/26/2026